$pennypuppet Sunday, 03/29/20 10:47:00 PM Re: iRobot post# 2712 Post # of 2718 Our pharmaceutical/biotechnology relationships are valuable in negotiating favorable licensing agreements for our clients. Many potential in-licensing companies are considering multiple products, and have challenges navigating the corporate “red tape” that often revolves around the capital requirements of in-licensing products. We help our clients understand the value proposition associated with each potential deal. It is in this way, that we are even considered value added to even an experienced business development team at a client company. Each transaction is unique. In one situation, we might assist on getting the right process in place. In another, the financial details and valuation might be the key negotiating hurdle. SunMed management has experience navigating all obstacles to help achieve a successful outcome. If you are you looking to diversifying your portfolio or pipeline, Sunmed has relationships with Universities that are looking to commercialize early stage products.? This can help you get access to the latest innovation. Given our global ( strong Asian ) presence we can introduce you to opportunities from all over the world. While the US remains the major source of healthcare innovation, countries such as Japan and China have made great strides as well. SunMed maintains excellent relationships all over the world.